EUVIMEDOpdag EUVIMED
Crossref

Asymmetric Synthesis of Noncanonical Prolines via a TrpB-IRED Enzymatic Cascade

Wenxuan Li, Noah X. Hamlish, Rodell C. Barrientos, Mengbin Chen, Anna Fryszkowska, Yining Ji, Chey M. Jones, Andrew W. Kelly, Mikhail Y. Reibarkh, Heather Wang, Matthew S. Winston, Richard S. Ayikpoe and 1 more

ACS Catalysis · 2026-06-19 · 16 (12) · 11478-11485

DOI: 10.1021/acscatal.6c02110 ↗

At a glance

Journal article in ACS Catalysis, published online on 2026-06-05. Written by Wenxuan Li and 12 co-authors. Cited 4 times so far (Crossref); 48 references. Funded by: Merck.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Noncanonical amino acids (ncAAs) are valuable building blocks for therapeutic design. Prolines are particularly useful because their cyclic cores can limit the conformational flexibility of a larger molecular framework, allowing such scaffolds to be further tuned to enhance engagement with their biological targets. Herein, we describe a convergent approach to synthesizing noncanonical prolines from readily available starting materials mediated by a tryptophan synthase β-subunit (TrpB)-imine reductase (IRED) cascade. In the first step, the TrpB catalyzes C−C bond formation between a ketone substrate and an l-serine- or l-threonine (l-Thr)-derived amino acrylate intermediate. In the second step, the IRED reduces the resulting cyclic imine, in some cases simultaneously setting two stereocenters via a dynamic kinetic resolution. With this one-pot, sequential cascade, we demonstrate the synthesis of mono-, bi-, and tricyclic prolines bearing as many as four chiral centers, including three examples that contain a remote desymmetrized stereocenter and one example featuring an l-Thr-derived, fully functionalized pyrrolidine ring. Furthermore, we show that a d-proline is formed from l-amino acid starting materials, which has not been observed in closed-shell tryptophan synthase catalysis previously. This cascade is a scalable, operationally simple method to synthesize new prolines, and is poised to expand the development of therapeutics featuring structurally complex ncAAs.

Funding

  • Merck

Cite

APA

Li, W., Hamlish, N. X., Barrientos, R. C., Chen, M., Fryszkowska, A., Ji, Y., Jones, C. M., Kelly, A. W., Reibarkh, M. Y., Wang, H., Winston, M. S., Ayikpoe, R. S., & Dunham, N. P. (2026). Asymmetric Synthesis of Noncanonical Prolines via a TrpB-IRED Enzymatic Cascade. ACS Catalysis, 16(12), 11478-11485. https://doi.org/10.1021/acscatal.6c02110

Vancouver

Li W, Hamlish NX, Barrientos RC, Chen M, Fryszkowska A, Ji Y, et al. Asymmetric Synthesis of Noncanonical Prolines via a TrpB-IRED Enzymatic Cascade. ACS Catalysis. 2026;16(12):11478-11485. doi:10.1021/acscatal.6c02110

BibTeX
@article{Li2026,
  author = {Li, Wenxuan and Hamlish, Noah X. and Barrientos, Rodell C. and Chen, Mengbin and Fryszkowska, Anna and Ji, Yining and Jones, Chey M. and Kelly, Andrew W. and Reibarkh, Mikhail Y. and Wang, Heather and Winston, Matthew S. and Ayikpoe, Richard S. and Dunham, Noah P.},
  title = {Asymmetric Synthesis of Noncanonical Prolines via a TrpB-IRED Enzymatic Cascade},
  journal = {ACS Catalysis},
  year = {2026},
  volume = {16},
  number = {12},
  pages = {11478--11485},
  doi = {10.1021/acscatal.6c02110}
}
Start for free →